EP1343481A4 - Process for the preparation of a fast dissolving dosage form - Google Patents

Process for the preparation of a fast dissolving dosage form

Info

Publication number
EP1343481A4
EP1343481A4 EP01270300A EP01270300A EP1343481A4 EP 1343481 A4 EP1343481 A4 EP 1343481A4 EP 01270300 A EP01270300 A EP 01270300A EP 01270300 A EP01270300 A EP 01270300A EP 1343481 A4 EP1343481 A4 EP 1343481A4
Authority
EP
European Patent Office
Prior art keywords
preparation
dosage form
fast dissolving
dissolving dosage
fast
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01270300A
Other languages
German (de)
French (fr)
Other versions
EP1343481A2 (en
Inventor
Deepak Murpani
Rajiv Malik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of EP1343481A2 publication Critical patent/EP1343481A2/en
Publication of EP1343481A4 publication Critical patent/EP1343481A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
EP01270300A 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form Withdrawn EP1343481A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
INDE117000 2000-12-15
IN1170DE2000 IN192750B (en) 2000-12-15 2000-12-15
PCT/IB2001/002354 WO2002047607A2 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Publications (2)

Publication Number Publication Date
EP1343481A2 EP1343481A2 (en) 2003-09-17
EP1343481A4 true EP1343481A4 (en) 2004-03-17

Family

ID=11097139

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01270300A Withdrawn EP1343481A4 (en) 2000-12-15 2001-12-07 Process for the preparation of a fast dissolving dosage form

Country Status (4)

Country Link
EP (1) EP1343481A4 (en)
AU (1) AU2002220968A1 (en)
IN (1) IN192750B (en)
WO (1) WO2002047607A2 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232113A1 (en) 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
KR100503949B1 (en) * 2003-04-28 2005-07-26 주식회사유한양행 A composition of fast dissolving tablets effectively masked bitter taste of ondansetron hydrochloride
FR2858556B1 (en) * 2003-08-06 2006-03-10 Galenix Innovations DISPERSIBLE AND / OR ORODISPERSIBLE SOLID PHARMACEUTICAL COMPOSITION, NOT PELLETIZED, CONTAINING AT LEAST THE METFORMIN ACTIVE INGREDIENT, AND PROCESS FOR PREPARING THE SAME
EP1510208A1 (en) 2003-08-22 2005-03-02 Fournier Laboratories Ireland Limited Pharmaceutical composition comprising a combination of metformin and statin
WO2005062722A2 (en) * 2003-11-21 2005-07-14 Sun Pharmaceutical Industries Limited Fexofenadine containing pharmaceutical formulation
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
EP2044929A1 (en) * 2007-10-04 2009-04-08 Laboratorios del Dr. Esteve S.A. Oral fast distintegrating tablets
ES2633449T3 (en) 2007-10-31 2017-09-21 Johnson & Johnson Consumer Inc. Orally disintegrable dose form
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose
US8871263B2 (en) 2009-09-24 2014-10-28 Mcneil-Ppc, Inc. Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
US20110318411A1 (en) 2010-06-24 2011-12-29 Luber Joseph R Multi-layered orally disintegrating tablet and the manufacture thereof
US8581001B2 (en) 2010-04-16 2013-11-12 Codman & Shurtleff Metformin-cysteine prodrug
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
CN102258497B (en) * 2011-08-18 2013-01-09 海南良方医药有限公司 Lamivudine tablet composition and preparation method thereof
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
CN103432091A (en) * 2013-09-13 2013-12-11 钟术光 Improved-performance tablet and preparation method thereof
WO2015105992A1 (en) 2014-01-10 2015-07-16 Mcneil-Ppc, Inc. Process for making tablet using radiofrequency and lossy coated particles
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
CA3129434A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
KR20210129649A (en) 2019-02-22 2021-10-28 카탈렌트 유.케이. 스윈던 지디스 리미티드 Minimize aggregation, aeration and preserve coating of pharmaceutical compositions containing ibuprofen
US11179331B1 (en) 2020-04-21 2021-11-23 Cure Pharmaceutcai Holding Corp Oral soluble film containing sildenafil citrate
SI3962455T1 (en) 2020-05-18 2022-11-30 Orexo Ab New pharmaceutical composition for drug delivery
EP4236921A1 (en) 2021-11-25 2023-09-06 Orexo AB Pharmaceutical composition comprising adrenaline

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166440A2 (en) * 1984-06-28 1986-01-02 THE PROCTER & GAMBLE COMPANY Antacid composition
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
EP0960621A2 (en) * 1998-05-15 1999-12-01 Pfizer Inc. Pharmaceutical formulations comprising sildenafil

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
AU691195B2 (en) * 1993-07-09 1998-05-14 R.P. Scherer Corporation Method for making freeze dried drug dosage forms
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
EP0893992B1 (en) * 1996-04-16 2004-03-03 Novartis Consumer Health S.A. Fast disintegrating oral dosage form

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166440A2 (en) * 1984-06-28 1986-01-02 THE PROCTER & GAMBLE COMPANY Antacid composition
GB2293099A (en) * 1994-09-15 1996-03-20 Mailway Packaging Group Ltd Drug formulation
WO1999043306A1 (en) * 1998-02-26 1999-09-02 Banyu Pharmaceutical Co., Ltd. An orally disintegrating composition and its manufacturing method
EP0960621A2 (en) * 1998-05-15 1999-12-01 Pfizer Inc. Pharmaceutical formulations comprising sildenafil

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0247607A3 *

Also Published As

Publication number Publication date
EP1343481A2 (en) 2003-09-17
WO2002047607A2 (en) 2002-06-20
AU2002220968A1 (en) 2002-06-24
IN192750B (en) 2004-05-15
WO2002047607A3 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
EP1343481A4 (en) Process for the preparation of a fast dissolving dosage form
EG24851A (en) Crystalline anticholinergic process for the preparation thereof for preparing a medicament
IL154012A0 (en) Hydrogel-driven drug dosage form
HK1046236A1 (en) Rapidly dissolving dosage form and process for making same
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
HUP0402027A3 (en) Process for the preparation of a xantophyll
HUP0204395A3 (en) A new process for the preparation of latanoprost
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
IL187126A0 (en) Process for the preparation of 4 - haloalkylnicotinonitriles
HK1039117B (en) New piperidine-4-sulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them
IL160193A0 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
HUP0104272A2 (en) New cyclobutendione compounds, a process for their preparation and pharmaceutical compositions containing them
IL153532A0 (en) Process for the preparation of pyrazolopyrimidinones
IL148176A0 (en) Bioavailable dosage form of isotretinoin
HK1048112B (en) Process for the preparation of a 3-vinylcephem compound
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
AU8824201A (en) Process for the preparation of dinapsoline
IL190807A0 (en) Process for the preparation of 2-aminoethylpyridines
IL150897A0 (en) Process for the preparation of acetyl-amidiniophenylalanyl cyclohexylglycyl-pyridinioalaninamides
GB0108016D0 (en) Process for the preparation of a catalyst
IL137364A0 (en) A process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
HK1040247A1 (en) New cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them
HRP20000490B1 (en) Process for the preparation of amlodipine besilate
GB0108017D0 (en) Process for the preparation of a catalyst
SI1339703T1 (en) A process for the preparation of paclitaxel

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

17P Request for examination filed

Effective date: 20030922

A4 Supplementary search report drawn up and despatched

Effective date: 20040204

17Q First examination report despatched

Effective date: 20060913

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070124